IL6 and non-small cell lung carcinoma: To further elucidate the role of IL-6 on NK cells within the NSCLC microenvironment, NK92 cells were treated with recombinant IL-6 protein, followed by an assessment of the expression levels of activating receptors and their cytotoxic function.